Skip to content

A study on the impact of positional changes during postoperative transport for obese patients on hypoxemia

A study on the impact of positional changes during postoperative transport for obese patients on hypoxemia

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
ChiCTR
Registry ID
ChiCTR2600121001
Enrollment
Unknown
Registered
2026-03-24
Start date
2025-07-23
Completion date
Unknown
Last updated
2026-08-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Hypoxemia

Interventions

Group :Raise the head of the bed 45° during transfer
Group B:Raise the head of the bed 30° during transfer
Group C:Lie flat during transport

Sponsors

the fourth affiliated hospital of china medical university
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 45 Years

Inclusion criteria

Inclusion criteria: 1. Aged from 18 to 45 years old, American Society of Anesthesiologists physical status II to III; 2. BMI 30 to 55 kg/m^2; 3. Patients undergoing elective laparoscopic sleeve gastrectomy; 4. Patients voluntarily signed informed consent; 5. Meet the standard of PACU: (1) Complete reversal of neuromuscular blockade (TOF ratio >=0.9); (2) SpO2 > 95%; (3) End-tidal carbon dioxide was normal; (4) No edema of the upper respiratory tract; (5) Aldrete score >=9.

Exclusion criteria

Exclusion criteria: 1. Patients with severe cardiovascular disease (ischemic heart disease, heart failure, severe angina attack, unstable angina within 6 months or myocardial infarction) and severe hypertension (systolic blood pressure (SBP) > 180 mmHg; or diastolic blood pressure (DBP) > 110 mmHg), hypotension (SBP < 90 mmHg); 2. Severe respiratory diseases (chronic obstructive pulmonary disease, respiratory failure, asthma, pulmonary bullae, recent upper respiratory tract infection, previous history of chest surgery) and hypoxemia (SpO2 < 92%); 3. Severe liver and kidney diseases; 4. Temporary change of surgical methods; patients whose operation duration was more than 3 hours; 5. Patients with known allergies to sufentanil citrate injection, propofol injection and other active ingredients or excipients used during surgery; 6. Patients with incomplete information or withdrawal requested by themselves or their family members.

Design outcomes

Primary

MeasureTime frame
The incidence of hypoxemia;Hypoxemia duration;

Secondary

MeasureTime frame
Occurrence of anesthesia-related adverse events after surgery;Patient comfort (VAS score);Arterial blood gas analysis (PaO2, PaCO2);Pulse oximetry;

Countries

China

Contacts

Public ContactJi Xuemei

The Fourth Affiliated Hospital of China Medical University

1945158994@qq.com+86 24 62043181

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Sep 19, 2026